05:57 PM EDT, 10/03/2024 (MT Newswires) -- Anish Bhatnagar, Director, CEO, on October 01, 2024, sold 21,633 shares in Soleno Therapeutics ( SLNO ) for $1,069,306. Following the Form 4 filing with the SEC, Bhatnagar has control over a total of 719,553 shares of the company, with 719,553 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1484565/000141588924024658/xslF345X05/form4-10032024_091036.xml